MedPath
FDA Approval

MORPHINE SULFATE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
STAT Rx USA LLC
DUNS: 786036330
Effective Date
April 23, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Morphine(30 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

PSS World Medical Inc.

101822682

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

STAT Rx USA LLC

STAT Rx USA LLC

PSS World Medical Inc.

786036330

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MORPHINE SULFATE

Product Details

NDC Product Code
42549-659
Application Number
NDA022207
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
February 28, 2012
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MorphineActive
Code: X3P646A2J0Class: ACTIBQuantity: 30 mg in 1 1
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT

MORPHINE SULFATE

Product Details

NDC Product Code
42549-602
Application Number
NDA022207
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
February 28, 2012
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MorphineActive
Code: X3P646A2J0Class: ACTIBQuantity: 15 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
© Copyright 2025. All Rights Reserved by MedPath